Skip to content

FDM PHARMA

Absorbed by PHARMACIE de MUNCK FRANCOIS on 09-02-2021 KBO/BCE: BE 0865.948.197

Lifetime

15 annual accounts with figures on one time axis, 17 filings since 2004
peak of €274,966 in 2020
€274,966▲ 17.8%
lowest -€40,190 in 2015
€104,278▲ 32.0%
peak of €298,269 in 2020
€298,269▲ 53.8%
€415,791▼ 15.9%
peak of 2.3 FTE in 2012
1.1 FTE▲ 37.5%
Board4 names since 2015
- 
Owners
100%
Documentsfilings and deeds
27-08-202127 days late
2020financial year
Gross margin from €233,348 to €274,966Result from €78,989 to €104,278Staff from 0.8 FTE to 1.1 FTEDemerger proposal: FDM Pharma splits off to PHARMACIE 01-12Equity from €193,991 to €298,269Debts from €494,558 to €415,791

Key points

from the 2020 annual accounts, the last ones filed

Equity

€298,269 ▲ 53.8%
€194,0002019€298,0002020

Equity rose in 2020 from €193,991 to €298,269.

Profit

5 years
201820192020

5 profitable years in a row. Profit of €104,278 in financial year 2020.

Filings

17 annual accounts since 2004
AprilJune31 JulyOctober2005201020152020

Seven of the last ten came late. The 2011 accounts came in latest, 79 days after the end of the period.

Board and ownership

last known board
Manager, until 2015
Manager, last mentioned in 2015
Manager, last mentioned in 2015
Manager, until 2015
Board & ownership

Recent changes

Merger: absorbed by PHARMACIE Dissolution of the company · Dissolved without liquidation · Cancellation of 695 shares · General meeting of 21-01-2021 · Gazette deed
Demerger proposal: FDM Pharma splits off to PHARMACIE PHARMACIE holds all the shares · Gazette deed
Company renamed from to FDM PHARMA Capital increase of €20,088 to €51,708 · The capital rose from €31,620 to €51,708, with 270 new shares · (manager) and (statutory manager) resign · General meeting of 18-03-2015 · Gazette deed
Merger: VADIPHAR takes over Company renamed from VADIPHAR to · Capital increase of €13,020 to €31,620 · The capital rose from €18,600 to €31,620, with 175 new shares · General meeting of 30-06-2011 · Gazette deed
All 31 events

Official details

Source: KBO
Status
Absorbed by PHARMACIE merger by absorption, February 2021
Activity
“Toutes opérations commerciales, industrielles, mobilières, immobilières, financières et de financement en ce compris l'importation…” (deed in French)From the articles, 17 activitiesNo NACE code in the KBO
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2020

≈ €660,000estimated
€714,060▲ 3.7%
Filing
Filed on 27-08-2021
Financials

Insights on FDM PHARMA

Absorbed by PHARMACIE in February 2021. The last annual accounts are for financial year 2020. The company was dissolved without liquidation.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about FDM PHARMA

What is the company number of FDM PHARMA?
The company number of FDM PHARMA is 0865.948.197. The VAT number is the same number with BE in front: BE 0865.948.197.
What is the legal form of FDM PHARMA?
The KBO register gives FDM PHARMA the legal form “SPRL”.
Is FDM PHARMA still active?
No. Absorbed in a merger on 09-02-2021.Company details
How many employees did FDM PHARMA have?
FDM PHARMA had an average of 1.1 full-time equivalents in financial year 2020, according to the filed annual accounts.Financials
What is the turnover of FDM PHARMA?
The turnover in financial year 2020 is about €660,000. This figure is estimated from the gross margin of €274,966 and 2,136 comparable companies of the same size. It probably lies between €390,000 and €1.1m. It is a rough estimate.
Is FDM PHARMA profitable?
In financial year 2020, FDM PHARMA made a profit of €104,278.
Where can I find the annual accounts of FDM PHARMA?
FDM PHARMA filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2020.

Next steps

Keep this company with today's facts in a case file.